TheProfitWatch

RAPT - RAPT Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
25.0 2.18 (8.7%) --- --- --- -2.0 (-7.98%) 1.77 (6.95%) 0.0 (0.0%) -1.99 (-7.95%)

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.65
Diluted EPS:
-0.65
Basic P/E:
-41.8077
Diluted P/E:
-41.8077
RSI(14) 1m:
56.07
VWAP:
27.12
RVol:

Events

Period Kind Movement Occurred At

Related News